159 related articles for article (PubMed ID: 17013849)
1. Cyclooxygenase 2 controversy: thoughts on the process of discovery, development, and assessment of benefit and risk of therapies for chronic immunoinflammatory diseases of uncertain autoimmune etiology.
Furst DE; Khanna D; Paulus HE
Arthritis Rheum; 2006 Oct; 55(5):683-6. PubMed ID: 17013849
[No Abstract] [Full Text] [Related]
2. Balancing the cyclooxygenase portfolio.
Armstrong PW
CMAJ; 2006 May; 174(11):1581-2. PubMed ID: 16717266
[No Abstract] [Full Text] [Related]
3. [Insight on the clinical pharmacology of non-steroidal anti-inflammatory drugs].
Maddison JE
Tijdschr Diergeneeskd; 2010 Jan; 135(2):54-8. PubMed ID: 20344966
[No Abstract] [Full Text] [Related]
4. [New epidemiologic data show: conventional NSAIDs need individual benefit-risk evaluation].
MMW Fortschr Med; 2005 Nov; 147(47):62-3. PubMed ID: 16370198
[No Abstract] [Full Text] [Related]
5. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048
[No Abstract] [Full Text] [Related]
6. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
Scheiman JM
Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Hermann M; Ruschitzka F
Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O; Solomon SD
Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Solomon SD
Curr Opin Cardiol; 2006 Nov; 21(6):613-7. PubMed ID: 17053413
[TBL] [Abstract][Full Text] [Related]
10. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
Nurmohamed MT
Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165
[No Abstract] [Full Text] [Related]
11. Gastroprotective strategies among NSAID users: guidelines for appropriate use in chronic illness.
Targownik LE; Thomson PA
Can Fam Physician; 2006 Sep; 52(9):1100-5. PubMed ID: 17279220
[TBL] [Abstract][Full Text] [Related]
12. [Overestimated].
Höer A; Häussler B
Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
[No Abstract] [Full Text] [Related]
13. [Coxibes--bullying of a drug class?].
Müller P; Simon B
MMW Fortschr Med; 2008 Jun; 150 Suppl 2():63-4. PubMed ID: 18712125
[No Abstract] [Full Text] [Related]
14. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
Monteleone G; Pallone F; Macdonald TT
Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?
Pruthi RS; Kouba E; Carson CC; Wallen EM
Urology; 2006 Nov; 68(5):917-23. PubMed ID: 17113880
[No Abstract] [Full Text] [Related]
16. [Cost study of NSAID use in rheumatoid arthritis based on recent therapeutic protocols].
Inotai A; Vincze Z
Acta Pharm Hung; 2008; 78(2):79-86. PubMed ID: 18807388
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment, drug approval, and liability.
Somberg JC
Am J Ther; 2006; 13(3):181-2. PubMed ID: 16772756
[No Abstract] [Full Text] [Related]
18. [Therapy of joint pain in arthrosis and arthritis. Classical nonsteroidal anti-inflammatory agents, coxibs--or opioids?].
Neumaier J
MMW Fortschr Med; 2009 Aug; 151(34-35):22-3. PubMed ID: 19771784
[No Abstract] [Full Text] [Related]
19. Why omega-3 fatty acids are important to neurosurgeons.
Ausman JI
Surg Neurol; 2006 Apr; 65(4):325. PubMed ID: 16531186
[No Abstract] [Full Text] [Related]
20. [Chemoprevention of colorectal cancer].
Stelmaszuk T; Jałocha L; Wojtuń S; Gil J
Pol Merkur Lekarski; 2009 May; 26(155):565-8. PubMed ID: 19606728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
